2. Academic Validation
  3. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

  • Nature. 2000 Apr 27;404(6781):995-9. doi: 10.1038/35010115.
J A Gross 1,  J Johnston,  S Mudri,  R Enselman,  S R Dillon,  K Madden,  W Xu,  J Parrish-Novak,  D Foster,  C Lofton-Day,  M Moore,  A Littau,  A Grossman,  H Haugen,  K Foley,  H Blumberg,  K Harrison,  W Kindsvogel,  C H Clegg
Affiliations

Affiliation

  • 1 Department of Immunology, ZymoGenetics, Seattle, Washington 98102, USA. grossj@zgi.com
PMID: 10801128 DOI: 10.1038/35010115
Abstract

B cells are important in the development of autoimmune disorders by mechanisms involving dysregulated polyclonal B-cell activation, production of pathogenic Antibodies, and co-stimulation of autoreactive T cells. zTNF4 (BLyS, BAFF, TALL-1, THANK) is a member of the tumour necrosis factor (TNF) ligand family that is a potent co-activator of B cells in vitro and in vivo. Here we identify two receptors for zTNF4 and demonstrate a relationship between zTNF4 and autoimmune disease. Transgenic Animals overexpressing zTNF4 in lymphoid cells develop symptoms characteristic of systemic lupus erythaematosus (SLE) and expand a rare population of splenic B-Ia lymphocytes. In addition, circulating zTNF4 is more abundant in NZBWF1 and MRL-lpr/lpr mice during the onset and progression of SLE. We have identified two TNF Receptor family members, TACI and BCMA, that bind zTNF4. Treatment of NZBWF1 mice with soluble TACI-Ig fusion protein inhibits the development of proteinuria and prolongs survival of the Animals. These findings demonstrate the involvement of zTNF4 and its receptors in the development of SLE and identify TACI-Ig as a promising treatment of autoimmune disease in humans.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z